Culture Biosciences is a biotechnology company based in South San Francisco, CA, that's building the future of biomanufacturing. Culture's digital biomanufacturing platform enables companies to run, monitor and analyze bioreactor experiments from the cloud. Culture is proud to count Section 32, Refactor Capital and Verily among its investors, and is a resident of the Verily Partner Space. To learn more, please visit www.culturebiosciences.com.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/12/19 | $5,500,000 | Venture |
Refactor Capital Section 32  Verily Life Sciences | undisclosed |
| 10/14/21 | $80,000,000 | Series B |
BoxGroup Craft Ventures Cultivian Sandbox Venture Partners E14 Fund Northpond Ventures Section 32 Synthesis Capital The Production Board Verily Life Sciences | undisclosed |
